GEROSA, GINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 48.027
AS - Asia 21.500
EU - Europa 13.539
AF - Africa 5.794
SA - Sud America 4.952
OC - Oceania 570
Continente sconosciuto - Info sul continente non disponibili 271
Totale 94.653
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 45.087
SG - Singapore 7.860
CN - Cina 3.955
BR - Brasile 3.025
HK - Hong Kong 2.375
IT - Italia 2.027
VN - Vietnam 1.497
DE - Germania 1.433
FI - Finlandia 1.293
SE - Svezia 913
PL - Polonia 687
FR - Francia 633
GB - Regno Unito 579
RU - Federazione Russa 564
UA - Ucraina 547
NL - Olanda 443
IN - India 426
AR - Argentina 383
MX - Messico 298
AT - Austria 261
ZA - Sudafrica 260
TR - Turchia 254
CI - Costa d'Avorio 253
IE - Irlanda 249
ID - Indonesia 244
KR - Corea 244
IQ - Iraq 235
CA - Canada 232
JP - Giappone 230
ES - Italia 227
BJ - Benin 218
CO - Colombia 205
AO - Angola 204
EC - Ecuador 197
MA - Marocco 185
VE - Venezuela 184
UZ - Uzbekistan 183
GR - Grecia 181
PY - Paraguay 180
CL - Cile 178
JO - Giordania 178
DZ - Algeria 177
IR - Iran 176
AL - Albania 171
IL - Israele 168
TN - Tunisia 168
SI - Slovenia 165
AZ - Azerbaigian 164
NI - Nicaragua 164
UY - Uruguay 164
CZ - Repubblica Ceca 161
PS - Palestinian Territory 160
CH - Svizzera 159
NP - Nepal 158
PH - Filippine 158
JM - Giamaica 157
RS - Serbia 157
SA - Arabia Saudita 157
BA - Bosnia-Erzegovina 156
BE - Belgio 156
BY - Bielorussia 155
LB - Libano 155
AE - Emirati Arabi Uniti 154
PK - Pakistan 154
DO - Repubblica Dominicana 153
GA - Gabon 152
KZ - Kazakistan 152
RO - Romania 152
EG - Egitto 149
LV - Lettonia 149
DK - Danimarca 148
KG - Kirghizistan 148
HN - Honduras 147
PE - Perù 147
TT - Trinidad e Tobago 147
MG - Madagascar 146
MY - Malesia 146
MZ - Mozambico 146
AM - Armenia 145
CV - Capo Verde 145
GF - Guiana Francese 144
HR - Croazia 144
PA - Panama 144
BO - Bolivia 143
MN - Mongolia 143
MU - Mauritius 142
SN - Senegal 142
BS - Bahamas 139
CD - Congo 139
CW - ???statistics.table.value.countryCode.CW??? 139
GM - Gambi 139
KH - Cambogia 139
LY - Libia 139
PT - Portogallo 139
SK - Slovacchia (Repubblica Slovacca) 139
BG - Bulgaria 137
CG - Congo 137
KE - Kenya 137
LC - Santa Lucia 137
NO - Norvegia 137
Totale 87.692
Salva come PNG Salva come JPEG
Città #
Fairfield 6.353
Ashburn 4.537
Singapore 4.173
Woodbridge 3.615
Chandler 3.182
Houston 2.961
Seattle 2.315
Hong Kong 2.257
Ann Arbor 2.170
Wilmington 2.077
Cambridge 2.047
Jacksonville 1.835
Beijing 1.193
Boardman 1.020
Santa Clara 915
Princeton 856
Los Angeles 635
San Diego 624
Helsinki 569
Munich 524
Padova 516
Ho Chi Minh City 457
Medford 457
Chicago 452
Bytom 415
Des Moines 380
Nanjing 377
Roxbury 330
New York 328
Hanoi 266
São Paulo 261
Abidjan 242
Hefei 222
Cotonou 209
Dong Ket 207
Guangzhou 197
Dublin 191
Buffalo 187
Salt Lake City 171
Luanda 169
Amman 168
London 165
Tashkent 165
Warsaw 159
Managua 158
Vienna 158
Baku 155
Libreville 146
Turku 145
Dakar 141
Milan 139
Montevideo 138
Antananarivo 137
Ulan Bator 136
Bishkek 133
Riga 133
Tokyo 132
Nassau 130
Phnom Penh 130
Castries 129
Dushanbe 129
Panama City 125
Conakry 123
Kampala 123
Nouakchott 123
Noumea 121
Andorra la Vella 120
Praia 119
Shenyang 116
Yerevan 114
Bridgetown 113
Lusaka 113
Maputo 112
Redondo Beach 112
Nairobi 111
Vientiane 111
Johannesburg 110
Tripoli 109
Willemstad 108
Bamako 107
Harare 107
Accra 106
Kinshasa 106
Kigali 105
Hebei 104
Stockholm 104
Havana 103
Dar es Salaam 102
Podgorica 101
Nuremberg 100
Reykjavik 100
Minsk 99
San José 99
Cayenne 97
Niamey 97
Brooklyn 96
Montreal 96
Addis Ababa 95
Seoul 95
Tbilisi 95
Totale 57.115
Salva come PNG Salva come JPEG
Nome #
A Comprehensive Comparison of Bovine and Porcine Decellularized Pericardia: New Insights for Surgical Applications 348
A Sterilization Method for Decellularized Xenogeneic Cardiovascular Scaffolds 270
Left ventricular assist device in the presence of subcutaneous implantable cardioverter defibrillator: Data from a multicenter experience 261
Prognosticating Mortality of Primary Cardiogenic Shock Requiring Extracorporeal Life Support: The RESCUE Score 260
Conduction disorders after aortic valve replacement with rapid-deployment bioprostheses: early occurrence and one-year evolution 260
Marginal versus Standard Donors in Heart Transplantation: Proper Selection Means Heart Transplant Benefit 260
Recurrent autoimmune myocarditis in a young woman during the coronavirus disease 2019 pandemic 259
Two Left Ventricular Pseudoaneurysms Complicating a Myocardial Infarction: The Impact of Cardiac Magnetic Resonance in the Acute Setting 258
Comparison of Efficacy and Cost of Iodine Impregnated Drape vs. Standard Drape in Cardiac Surgery: Study in 5100 Patients 244
The influence of heart valve leaflet matrix characteristics on the interaction between human mesenchymal stem cells and decellularized scaffolds. 234
Multicentre experience with the evolution rl mechanical sheath for lead extraction using a stepwise approach: safety, effectiveness and outcome 233
Results with syncardia total artificial heart beyond one year 229
Endomyocardial fibrosis and myocardial infarction leading to diastolic and systolic dysfunction requiring transplantation 228
Navigating the Heart. The Evolution of the AngioVac System in a Single-center Experience 227
Circulating extracellular vesicles as non-invasive biomarker of rejection in heart transplant 227
Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve 222
Acute intraoperative echocardiographic changes after transapical off-pump mitral valve repair with NeoChord implantation 222
Bioengineered tissue solutions for repair, correction and reconstruction in cardiovascular surgery 222
Clones of Interstitial Cells From Bovine Aortic Valve Exhibit Different Calcifying Potential When Exposed to Endotoxin and Phosphate 220
MODULATION OF MICRORNA EXPRESSION IN HUMAN T CELL DEVELOPMENT: TARGETING OF NOTCH3 BY MIR-150 220
Bioengineered percutaneous heart valves for transcatheter aortic valve replacement: a comparative evaluation of decellularised bovine and porcine pericardia 220
Human cytomegalovirus-specific T-cell immune reconstitution in preemptively treated heart transplant recipients identifies subjects at critical risk for infection 219
Differential availability/processing of decorin precursor in arterial and venous smooth muscle cells 215
Decellularized aortic conduits: could their cryopreservation affect post-implantation outcomes? A morpho-functional study on porcine homografts 215
Multimodal label-free ex vivo imaging using a dual-wavelength microscope with axial chromatic aberration compensation 215
Decellularized Allogeneic Heart Valves Demonstrate Self-Regeneration Potential after a Long-Term Preclinical Evaluation 214
C2 is superior to C0 as predictor of renal toxicity and rejection risk profile in stable heart transplant recipients. 214
3D-printing model for complex aortic transcatheter valve treatment 211
Coronavirus disease 2019 (COVID-19) in the heart transplant population: a single-centre experience 210
Different cardiovascular potential of adult- and fetal-type mesenchymal stem cells in a rat model of heart cryoinjury. 209
Coronary Artery Bypass Grafting in Elderly Patients: Insights from a Comparative Analysis of Total Arterial and Conventional Revascularization 209
RegenHeart: A Time-Effective, Low-Concentration, Detergent-Based Method Aiming for Conservative Decellularization of the Whole Heart Organ 207
Evidence of complement activation in the thrombotic small vessels of a patient with catastrophic antiphospholipid syndrome treated with eculizumab 205
Early and mid-term outcomes of 1904 patients undergoing transcatheter balloon-expandable valve implantation in Italy: results from the Italian Transcatheter Balloon-Expandable Valve Implantation Registry (ITER) 203
Minimally invasive implantation of continuous flow left ventricular assist devices: the evolution of surgical techniques in a single centre experience 203
Can C4d immunostaining on endomyocardial biopsies be considered a prognostic biomarker in heart transplant recipients? 202
Abnormal total ejection isovolume index as early noninvasive marker of chronic rejection in heart transplantation 202
How to implant the Jarvik 2000 post-auricular driveline: evolution to a novel technique 202
The Rapidly Evolving Concept of Whole Heart Engineering 201
Nanopatterned acellular valve conduits drive the commitment of blood-derived multipotent cells 199
MicroRNA signatures in cardiac biopsies and detection of allograft rejection 199
A comparison of quality of life and psychological distress in heart transplantation patients at adult and pediatric ages 198
A step-by-step problem-solving strategy in a patient with heart failure and cerebral aneurysm 198
Guided Tissue Regeneration in Heart Valve Replacement: From Preclinical Research to First-in-Human Trials 197
Transcatheter aortic valve implantation and bleeding: Focus on Valve Academic Research Consortium-2 classification. 197
Cardiac arrest due to acute massive aortic root thrombosis after pericardial bioprosthetic aortic valve replacement 197
Preservation strategies for decellularized pericardial scaffolds for off-the-shelf availability 196
Porcine Small Intestinal Submucosa (SIS) as a Suitable Scaffold for the Creation of a Tissue-Engineered Urinary Conduit: Decellularization, Biomechanical and Biocompatibility Characterization Using New Approaches 196
Impact of Changes in Left Ventricular Ejection Fraction on Survival After Transapical Aortic Valve Implantation 195
Comprehensive effects of left ventricular assist device speed changes on alveolar gas exchange, sleep ventilatory pattern, and exercise performance 195
Biventricular assistance with 2 hm3 in a small chest patient: extra-pericardial implant 195
Continuous engraftment and differentiation of male recipient Y-chromosome-positive cardiomyocytes in donor female human heart transplants 194
Alpha-Gal detectors in xenotransplantation research: a word of caution. 194
Interventricular conduction disorders after orthotopic heart transplantation: risk factors and clinical relevance 194
Coronary microvascular dysfunction correlates with the new onset of cardiac allograft vasculopathy in heart transplant patients with normal coronary angiography. 193
Trans-subclavian versus transapical access for transcatheter aortic valve implantation: A multicenter study 193
Early and Mid-Term Results of Rapid Deployment Valves: The Intuity Italian Registry (INTU-ITA) 193
Endomyocardial biopsy under echocardiographic monitoring 192
The rise of new technologies for aortic valve stenosis: A comparison of sutureless and transcatheter aortic valve implantation 191
Physiological Performance of a Detergent Decellularized Heart Valve Implanted for 15 Months in Vietnamese Pigs: Surgical Procedure, Follow-up, and Explant Inspection. 191
Photo-realistic 3D Echocardiographic View of the Mitral Valve 190
From bench to bedside: Can the improvements in left ventricular assist device design mitigate adverse events and increase survival? 189
Intermediate clinical and hemodynamic outcomes after transcatheter aortic valve implantation presented at the fifty-first annual meeting of the society of thoracic surgeons, San Diego, CA, Jan 24-28, 2015 188
Decellularized Cryopreserved Allografts as Off-the-Shelf Allogeneic Alternative for Heart Valve Replacement: In Vitro Assessment Before Clinical Translation 188
Subcutaneous implantable cardioverter defibrillator in patients awaiting cardiac transplantation or left ventricular assist device for refractory heart failure: a feasible alternative to transvenous device? 188
Irreversible cardiac failure with intraventricular thrombosis: A novel technique of paracorporeal biventricular assist device implantation with ventricles excision 188
Early and Midterm Clinical and Hemodynamic Outcomes of Transcatheter Valve-in-Valve Implantation: Results From a Multicenter Experience 187
Impaired endothelial progenitor cell recruitment may contribute to heart transplant microvasculopathy. 185
Transcatheter aortic valve implantation in patients with severe left ventricular dysfunction: immediate and mid-term results, a multicenter study. 185
In vitro comparative assessment of decellularized bovine pericardial patches and commercial bioprosthetic heart valves 185
Prognostic impact of leaflet-to-annulus index in patients treated with transapical off-pump echo-guided mitral valve repair with NeoChord implantation 185
Heart transplantation management in northern Italy during COVID-19 pandemic: single-centre experience 185
Safety and effectiveness of a selective strategy for coronary artery revascularization before transcatheter aortic valve implantation. 184
Does pre-existing aortic regurgitation protect from death in patients who develop paravalvular leak after TAVI? 184
Intravascular macrophages in cardiac allograft biopsies for diagnosis of early and late antibody-mediated rejection. 184
Incidence, Predictors, and Outcome of Conduction Disorders After Transcatheter Self-Expandable Aortic Valve Implantation. 184
Native Bovine and Porcine Pericardia Respond to Load With Additive Recruitment of Collagen Fibers 184
Pulmonary embolism and LVAD: Is there compatibility? 183
A pilot study on the efficacy and safety of a minimally invasive surgical and anesthetic approach for ventricular assist device implantation 183
Transapical Deployment of Thoracic Stent Graft for Ascending Aorta Coronary Bypass Pseudoaneurysm in a Patient with Prosthetic Aortic Valve 183
Impact of type of intervention for aortic valve replacement on heart rate variability 182
Cells, scaffolds and bioreactors for tissue engineered heart valves: a journey from basic concepts to contemporary developmental innovations 181
Mechanical testing of pericardium for manufacturing prosthetic heart valves 181
Preliminary Computational Analysis of Three Configurations for an Innovative Ventricular Chamber 181
The vietnamese pig as a translational animal model to evaluate tissue engineered heart valves: Promising early experience 181
Acute Increase of Cardiac Output Reduces Central Sleep Apneas in Heart Failure Patients 180
Use of freedom SOLO bioprosthesis in aortic valve endocarditis involving the annulus 180
Thromboelastometry guided fibrinogen replacement therapy in cardiac surgery: a retrospective observational study 179
The Psychosocial Assessment of Transplant Candidates: Inter-Rater Reliability and Predictive Value of the Italian Stanford Integrated Psychosocial Assessment for Transplantation 179
Successful jugular implantable defibrillator lead extraction with bidirectional rotational mechanical sheath 179
Against Odds of Prolonged Warm Ischemia: Early Experience With DCD Heart Transplantation After 20-Minute No-Touch Period 179
Intracoronary artery shunt: an assessment of possible coronary artery wall damage 178
Cardiac rehabilitation after transcatheter versus surgical prosthetic valve implantation for aortic stenosis in the elderly. 178
A word of caution for patients undergoing lung transplantation with associated mitral regurgitation 178
First quantitative assay of alpha-Gal in soft tissues: presence and distribution of the epitope before and after cell removal from xenogeneic heart valves. 178
Orthotopic heart transplantation: the bicaval technique 178
Patient-Specific Ventricular Access Site Selection for the NeoChord Mitral Valve Repair Procedure 178
Comparative classification of thrombotic formations on bileaflet mechanical heart valves by phonographic analysis 177
Differential distribution of structural components and hydration in aortic and pulmonary heart valve conduits: Impact of detergent-based cell removal 177
Neuropsychological profile in a large group of heart transplant candidates 177
Totale 20.270
Salva come PNG Salva come JPEG
Categoria #
all - tutte 301.161
article - articoli 278.704
book - libri 346
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.776
Totale 584.987
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215.368 0 0 0 0 0 560 549 702 1.114 1.005 830 608
2021/20228.672 215 1.086 1.012 697 361 664 428 934 544 179 755 1.797
2022/20236.308 1.336 707 179 765 937 772 37 379 748 57 285 106
2023/20243.528 154 516 424 259 239 340 293 171 164 182 355 431
2024/202515.771 104 1.006 634 600 1.919 602 897 1.311 1.372 699 2.660 3.967
2025/202635.957 2.892 5.401 9.563 10.902 6.166 1.033 0 0 0 0 0 0
Totale 95.449